Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

被引:2
|
作者
Decary, Simon [1 ]
de Wit, Maarten [2 ]
Naye, Florian [1 ]
Barton, Jennifer L. [3 ]
Fraenkel, Liana [4 ]
Li, Linda C. [5 ,6 ]
Brooks, Peter [7 ,8 ]
Stacey, Dawn [9 ,10 ]
Maxwell, Lara J. [11 ,12 ]
Campbell, Willemina [13 ]
Hofstetter, Cathie
Voshaar, Marieke [14 ,15 ,16 ]
Meara, Alexa [17 ]
Christensen, Robin [18 ,19 ]
Boonen, Annelies [20 ,21 ]
Suarez-Almazor, Maria E. [22 ]
Meade, Tanya [23 ]
March, Lyn [24 ]
Jull, Janet Elizabeth [25 ]
Alten, Rieke [26 ]
Morgan, Esi M. [27 ]
Hazlewood, Glen Stewart [28 ]
Barber, Claire E. H. [29 ]
Guillemin, Francis [30 ]
El-Miedany, Yasser [31 ,32 ]
Mittoo, Shikha [33 ]
Robertson, Tiffany Westrich [34 ]
Bartlett, Susan J. [35 ,36 ,37 ]
Singh, Jasvinder A. [38 ]
Mannion, Melissa [39 ]
Nasef, Samah Ismail [40 ]
Boel, Anne [41 ,42 ]
Adebajo, Adewale [43 ]
Arnaud, Laurent [44 ]
Gill, Tiffany K. [45 ]
Moholt, Ellen [46 ]
Burt, Jennifer [47 ]
Jayatilleke, Arundathi [48 ]
Hmamouchi, Ihsane [49 ]
Berthelsen, Dorthe B. [50 ,51 ,52 ]
Blanco, Francisco J. [53 ]
Mather, Kate [54 ]
Maharaj, Ajesh [55 ]
Sharma, Saurab [56 ,57 ]
Caso, Francesco [58 ]
Beaton, Dorcas [59 ]
Shea, Beverly [60 ,61 ,62 ]
Fong, Christopher [63 ]
Fernandez, Anthony P. [64 ,65 ]
Mackie, Sarah [66 ]
机构
[1] Univ Sherbrooke, Sch Rehabil,Fac Med & Hlth Sci, Res Ctr,CHUS, CIUSSS EstrieCHUS, Sherbrooke, PQ, Canada
[2] Patient Res Partner, Amsterdam, Netherlands
[3] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Portland, OR USA
[4] Yale Univ, Dept Internal Med, New Haven, CT USA
[5] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada
[6] Arthrit Res Canada, Vancouver, BC, Canada
[7] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Australia
[8] Northern Hlth, Melbourne, Australia
[9] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada
[10] Ottawa Hosp Res Inst, Ottawa, ON, Canada
[11] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada
[12] Univ Ottawa, Fac Med, Ottawa, ON, Canada
[13] Toronto Western Hosp, Univ Hlth Network, Patient Res Partner, Toronto, ON, Canada
[14] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands
[15] Sint Maartenskliniek, Dept Res Innovat, Nijmegen, Netherlands
[16] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, Nijmegen, Netherlands
[17] Ohio State Univ, Div Rheumatol, Columbus, OH USA
[18] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark
[19] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark
[20] Maastricht Univ, Div Rheumatol, Dept Internal Med, Med Ctr, Maastricht, Netherlands
[21] Maastricht Univ, Caphri Res Inst, Maastricht, Netherlands
[22] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX USA
[23] Western Sydney Univ, Sydney, NSW, Australia
[24] Royal North Shore Hosp Univ Sydney, Dept Rheumatol, Sydney, Australia
[25] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada
[26] Univ Med Berlin, Dept Internal Med 2, Schlosspark Klin,Rheumatol Res Ctr, Clin Immunol Osteol Phys Therapy & Sports Med, Berlin, Germany
[27] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Rheumatol, Seattle, WA USA
[28] Univ Calgary, Dept Med, Calgary, AB, Canada
[29] Univ Calgary, Cumming Sch Med, Dept Med, Dept Community Hlth Sci, Calgary, AB, Canada
[30] Univ Lorraine, INSPIIRE, INSERM, Nancy, France
[31] Canterbury Kings Coll London, Canterbury, Kent, England
[32] Kings Coll London, London, England
[33] Vanshavardhana Canada Integrated Hlth, Toronto, ON, Canada
[34] Int Fdn Autoimmune & Autoinflammatory Arthrit Ai, New York, NY USA
[35] McGill Univ, Div Clin Epidemiol, Rheumatol & Resp Epidemiol & Clin Trials Unit, Montreal, PQ, Canada
[36] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada
[37] Johns Hopkins Med, Div Rheumatol, Montreal, PQ, Canada
[38] Univ Alabama Birmingham, Birmingham, AL USA
[39] Univ Alabama Birmingham, Div Pediat Rheumatol, Dept Pediat, Birmingham, AL USA
[40] Suez Canal Univ, Dept Rheumatol & Rehabil, Fac Med, Ismailia, Egypt
[41] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands
[42] UCB Pharma B V Netherlands, Leiden, Netherlands
[43] Univ Sheffield, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England
[44] Univ Hosp Strasbourg, Dept Rheumatol, CRMR RESO, Strasbourg, France
[45] Univ Adelaide, Adelaide Med Sch, Fac Hlth & Med Sci, Adelaide, SA, Australia
[46] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[47] St Clares Mercy Hosp, Newfoundland & Labrador Hlth Serv, St John, NF, Canada
[48] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA USA
[49] Int Univ Rabat UIR, Hlth Sci Res Ctr CReSS, Fac Med, Rabat, Morocco
[50] Bispebjerg & Frederiksberg Hosp, Parker Inst, Sect Biostat & Evidence Based Res, Copenhagen, Denmark
基金
加拿大健康研究院; 美国国家卫生研究院;
关键词
OMERACT; Rheumatology; Shared decision making; Core domain set; Consensus-building; Survey;
D O I
10.1016/j.semarthrit.2024.152381
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions. Methods: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains. Results: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/ researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains. Conclusion: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set. Clinical significance: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol
    Lara S. Chapman
    Anthony C. Redmond
    Caroline A. Flurey
    Pamela Richards
    Toby O. Smith
    John B. Arnold
    Dorcas Beaton
    Philip G. Conaghan
    Yvonne M. Golightly
    Marian T. Hannan
    Catherine Hofstetter
    Lara J. Maxwell
    Hylton B. Menz
    Beverley Shea
    Peter Tugwell
    Philip Helliwell
    Heidi J. Siddle
    Trials, 24
  • [32] A core outcome set for adult cardiac surgery trials: A consensus study
    Benstoem, Carina
    Moza, Ajay
    Meybohm, Patrick
    Stoppe, Christian
    Autschbach, Ruediger
    Devane, Declan
    Goetzenich, Andreas
    PLOS ONE, 2017, 12 (11):
  • [33] Consensus-agreed core outcome set for use in atopic eczema trials: the Harmonizing Outcome Measures for Eczema core outcome set
    Thomas, K.
    Schmitt, J.
    Apfelbacher, C.
    Simpson, E.
    Spuls, P.
    Chalmers, J.
    Gerbens, L.
    Williams, H.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 183 : 47 - 47
  • [34] A core set of domains for longitudinal observational studies in rheumatic disorders:: Consensus report from OMERACT 4.
    Wolfe, F
    Laserre, M
    van der Heidie, D
    Stücki, G
    Suarez-Almazor, M
    Pincus, T
    Eberhardt, K
    Kvien, T
    Symmons, D
    Silman, A
    van Riel, P
    Tugwell, P
    Boers, M
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S204 - S204
  • [35] Addressing Challenges in Developing a Core Domain Set in Adherence Interventions in Rheumatology: A Report from the OMERACT-Adherence Group
    Kelly, Ayano
    Bartlett, Susan J.
    de Wit, Maarten P.
    Beaton, Dorcas E.
    Dawson, Therese
    Evans, Vicki
    Gill, Michael
    Hassett, Geraldine
    March, Lyn
    Scholte-Voshaar, Marieke
    Singh, Jasvinder A.
    Tong, Allison
    Tugwell, Peter
    Wong, Peter
    Tymms, Kathleen
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (09) : 1202 - 1206
  • [36] Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set
    Nielsen, Wils
    Kharouf, Fadi
    Grajales, Carolina Munoz
    Thayaparan, Aarabi
    Anderson, Melanie
    Strand, Vibeke
    Simon, Lee
    Bonilla, Dennisse
    Morand, Eric
    Thumboo, Julian
    Aringer, Martin
    Mosca, Marta
    Bruce, Ian
    Papadopoulos, Elektra J.
    Torralba, Karina D.
    Whitall-Garcia, Laura Patricia
    Rosen, Cheryl F.
    Parodis, Ioannis
    Kim, Alfred
    Desai, Maya
    Enman, Yvonne
    Shea, Beverley
    Wallace, Daniel J.
    Chaichian, Yashaar
    Navarra, Sandra
    Aranow, Cynthia
    Mackay, Meggan
    Trotter, Kimberly
    Tayer-Shifman, Oshrat E.
    Duarte-Garcia, Ali
    Tam, Lai Shan
    Ugarte-Gil, Manuel F.
    Pons-Estel, Guillermo J.
    Reynolds, John A.
    Nikpour, Mandana
    Hoi, Alberta
    Romero-Diaz, Juanita
    Aggarwalqq, Amita
    Papachristos, Danae
    Mok, Chi Chiu
    Fujio, Keishi
    Ramsey-Goldman, Rosalind
    Legge, Alexandra
    Arnaud, Laurent
    Bultink, Irene E. M.
    Finzel, Stephanie
    Voll, Reinhard E.
    Ruiz-Irastorza, Guillermo
    Ines, Luis Sousa
    Appenzeller, Simone
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2025, 72
  • [37] Standardising definitions for the pre-eclampsia core outcome set: A consensus development study
    Duffy, James M. N.
    Cairns, Alexandra E.
    Magee, Laura A.
    Dadelszen, Peter von
    Van't Hooft, Janneke
    Gale, Chris
    Brown, Mark
    Chappell, Lucy C.
    Grobman, William A.
    Fitzpatrick, Ray
    Karumanchi, S. Ananth
    Lucas, D. Nuala
    Mol, Ben
    Stark, Michael
    Thangaratinam, Shakila
    Wilson, Mathew J.
    Williamson, Paula R.
    Ziebland, Sue
    McManus, Richard J.
    PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2020, 21 : 208 - 217
  • [38] Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: Consensus on a preliminary core set of outcome domains
    Smolen, JS
    Strand, V
    Cardiel, M
    Edworthy, S
    Furst, D
    Gladman, D
    Gordon, C
    Isenberg, DA
    Klippel, JH
    Petri, M
    Simon, L
    Tugwell, P
    Wolfe, F
    JOURNAL OF RHEUMATOLOGY, 1999, 26 (02) : 504 - 507
  • [39] The "Outcome Reporting in Brief Intervention Trials: Alcohol" (ORBITAL) Core Outcome Set: International Consensus on Outcomes to Measure in Efficacy and Effectiveness Trials of Alcohol Brief Interventions
    Shorter, Gillian W.
    Bray, Jeremy W.
    Heather, Nick
    Berman, Anne H.
    Giles, Emma L.
    Clarke, Mike
    Barbosa, Carolina
    O'Donnell, Amy J.
    Holloway, Aisha
    Riper, Heleen
    Daeppen, Jean-Bernard
    Monteiro, Maristela G.
    Saitz, Richard
    McNeely, Jennifer
    McKnight-Eily, Lela
    Cowell, Alex
    Toner, Paul
    Newbury-Birch, Dorothy
    JOURNAL OF STUDIES ON ALCOHOL AND DRUGS, 2021, 82 (05) : 638 - 646
  • [40] Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis. Consensus development at OMERACT III
    Bellamy, N
    Kirwan, J
    Boers, M
    Brooks, P
    Strand, V
    Tugwell, P
    Altman, R
    Brandt, K
    Dougados, M
    Lequesne, M
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (04) : 799 - 802